Pneumocystis jirovecii pneumonia (PCP) DNA EQA/PT Scheme

To assess laboratories ability in the molecular detection of Pneumocystis jirovecii .

To assess the sensitivity of molecular assays in routine clinical use for the detection of P. jirovecii.

Total Number of Challenges: 1
Number of Panel Members: 10
Distribution / Testing Period: Q3
Sample NA Target Source Clinical material
Matrix Panel Format Physiological Buffer
Panel Member Target Range Covering clinical range
Panel Member Sample Volume 0.5 ml
Panel Sample Pre-treatment Requirement Ready for analysis. Treat as clinical samples and analyse accordingly.
Panel Analysis Type Qualitative. Quantitative for information purposes only
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043
SKU: QAF114144_1 Categories: , , , Tags: ,

$1,149.49